Stenger Family Office’s Bristol-Myers Squibb BMY Stock Holding History

Stenger Family Office’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$2.43M	Buy	+42,995	New	+$2.4M	0.83%	29

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stenger Family Office's BMY Position: Q4 2024 in Review

Stenger Family Office opened a new position in Bristol-Myers Squibb (BMY) in Q4 2024: 42,995 shares worth $2.43M. The stake represents 0.83% of the portfolio and ranks #29 among its holdings.

2,488 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

Stenger Family Office held 42,995 shares of Bristol-Myers Squibb worth $2.43M as of Q4 2024.
Bristol-Myers Squibb was a new Stenger Family Office position in Q4 2024.
Bristol-Myers Squibb made up 0.83% of Stenger Family Office's portfolio in Q4 2024, its #29 holding.
2,488 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Stenger Family Office's 13F filing for Q4 2024, filed 13 Feb 2025.